Your browser doesn't support javascript.
loading
Systematic review of the use of translated patient-reported outcome measures in cancer trials.
Slade, A L; Retzer, A; Ahmed, K; Kyte, D; Keeley, T; Armes, J; Brown, J M; Calman, L; Gavin, A; Glaser, A W; Greenfield, D M; Lanceley, A; Taylor, R M; Velikova, G; Turner, G; Calvert, M J.
Afiliación
  • Slade AL; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. a.l.slade@bham.ac.uk.
  • Retzer A; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, UK. a.l.slade@bham.ac.uk.
  • Ahmed K; National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre, University of Birmingham, Birmingham, West Midlands, UK. a.l.slade@bham.ac.uk.
  • Kyte D; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
  • Keeley T; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Armes J; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
  • Brown JM; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, UK.
  • Calman L; National Cancer Research Institute (NCRI) Psychosocial Oncology and Survivorship Clinical Studies Group subgroup: Understanding and measuring the consequences of cancer and its treatment, London, UK.
  • Gavin A; Patient Centred Outcomes, GlaxoSmithKline, Brentford, UK.
  • Glaser AW; National Cancer Research Institute (NCRI) Psychosocial Oncology and Survivorship Clinical Studies Group subgroup: Understanding and measuring the consequences of cancer and its treatment, London, UK.
  • Greenfield DM; School of Health Sciences, University of Surrey, Guildford, UK.
  • Lanceley A; NIHR Applied Research Collaboration Kent Surrey & Sussex University of Surrey, Guildford, UK.
  • Taylor RM; Clinical Trials Research Unit, University of Leeds, Leeds, UK.
  • Velikova G; National Cancer Research Institute (NCRI) Psychosocial Oncology and Survivorship Clinical Studies Group subgroup: Understanding and measuring the consequences of cancer and its treatment, London, UK.
  • Turner G; Macmillan Survivorship Research Group, Health Sciences, University of Southampton, Highfield Campus, Southampton, UK.
  • Calvert MJ; National Cancer Research Institute (NCRI) Psychosocial Oncology and Survivorship Clinical Studies Group subgroup: Understanding and measuring the consequences of cancer and its treatment, London, UK.
Trials ; 22(1): 306, 2021 Apr 26.
Article en En | MEDLINE | ID: mdl-33902699
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Medición de Resultados Informados por el Paciente / Neoplasias Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Medición de Resultados Informados por el Paciente / Neoplasias Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido